Releases
AnX Robotica Cites FDA Data Showing 88.6% Reduction in Capsule Review Time
NaviCam ProScan technology has emerged as a high-performance benchmark for gastrointestinal imaging, with FDA documentation revealing an 88.6% reduction in mean small-bowel review times. This performance metric significantly outpaces a recently cleared competitive AI platform, which reported a 24.7% efficiency gain in its own regulatory submission.

















